Acute gastritis

K11_ACUTGASTR

chronic gastritis: Inflammation of the stomach that is chronic in nature.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K29.0, K29.1 Hospital discharge: ICD-9 — 5350 Hospital discharge: ICD-8 — 3530[0-2] Cause of death: ICD-10 — K29.0, K29.1 Cause of death: ICD-9 — 5350 Cause of death: ICD-8 — 3530[0-2] 2 out of 7 registries used, show all original rules.	3632
4. Check minimum number of events None	3632
5. Include endpoints None	3632
6. Filter based on genotype QC (FinnGen only)	3211

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_ACUTGASTR
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K29[0-1]
HD_ICD_9	5350
HD_ICD_8	3530[0-2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K29[0-1]
COD_ICD_9	5350
COD_ICD_8	3530[0-2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute gastritis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	29046	14553	14180
Only index persons	22721	11717	11004
Unadjusted period prevalence (%)
Whole population	0.41	0.42	0.40
Only index persons	0.43	0.43	0.42
Median age at first event (years)
Whole population	59.00	62.12	55.63
Only index persons	55.57	58.04	52.93

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3211	1694	1517
Unadjusted period prevalence (%)	0.65	0.60	0.70
Median age at first event (years)	56.78	54.49	59.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3319: Matched controls
33190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

46.9

316.5

186

A02BC05

ATC

esomeprazole; systemic

3.8

314.4

1830

8093

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.8

309.7

1687

7126

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

28.0

307.7

574

246

A02BC03

ATC

lansoprazole; oral

4.1

307.7

1498

5511

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

11.6

307.7

441

434

5350A

ICD-9 Finland

Gastritis and duodenitis, Acute gastritis

+∞

307.7

392

K29.1

ICD-10 Finland

Other acute gastritis

2290.3

307.7

1925

K29.3

ICD-10 Finland

Chronic superficial gastritis

88.5

307.7

192

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

15.1

307.7

2139

3565

K29.7

ICD-10 Finland

Gastritis, unspecified

25.4

307.7

243

103

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3524.1

307.7

1046

UJD02

NOMESCO Finland

Gastroscopy

10.9

306.7

345

350

UJF32

NOMESCO Finland

Coloscopy

3.7

272.7

1323

5097

K30

ICD-10 Finland

Functional dyspepsia

5.9

266.7

533

1039

A02BC01

ATC

omeprazole; systemic

3.5

253.6

1320

5276

A02BA02

ATC

ranitidine; systemic

3.8

252.6

1022

3468

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

6.7

248.4

428

720

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.7

212.1

866

2919

K92.0

ICD-10 Finland

Haematemesis

12.2

200.3

204

177

A02BC02

ATC

pantoprazole; systemic

3.6

197.7

2646

17421

K92.1

ICD-10 Finland

Melaena

5.2

149.4

327

681

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

141.3

1210

5993

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

76.7

139.6

K29.4

ICD-10 Finland

Chronic atrophic gastritis

24.7

135.5

N02AX02

ATC

tramadol; systemic, rectal

2.4

131.4

1693

10024

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

61.3

129.4

A03FA02

ATC

cisapride; oral, rectal

4.0

122.1

379

1036

K29.6

ICD-10 Finland

Other gastritis

35.3

120.7

A02BC04

ATC

rabeprazole; oral

3.8

111.2

372

1069

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

110.2

605

2354

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

109.9

795

3565

A02BA04

ATC

nizatidine; systemic

3.7

109.4

388

1160

D64.9

ICD-10 Finland

Anaemia, unspecified

3.0

104.1

533

1991

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.4

102.7

401

1274

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

100.3

447

1540

K20

ICD-10 Finland

Oesophagitis

16.7

98.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

98.6

730

3292

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

134.2

97.6

104

N03AX16

ATC

[U] pregabalin

2.4

97.4

911

4568

R11

ICD-10 Finland

Nausea and vomiting

3.2

93.0

401

1352

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

92.8

1020

5459

R06.0

ICD-10 Finland

Dyspnoea

2.2

90.6

1079

5954

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.1

87.8

190

389

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

87.2

1759

11783

A02BA03

ATC

famotidine; systemic

4.8

86.7

203

444

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

85.8

869

4474

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

84.3

643

2921

R07.3

ICD-10 Finland

Other chest pain

2.9

84.0

458

1760

K29.8

ICD-10 Finland

Duodenitis

417.7

82.3

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

14.3

81.1

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

+∞

79.5

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

7.2

78.5

118

169

C03CA01

ATC

furosemide; systemic

2.0

78.3

1283

7891

P01AB01

ATC

metronidazole; oral, rectal

2.0

75.5

1361

8628

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.4

73.5

284

891

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

73.2

836

4478

K22.1

ICD-10 Finland

Ulcer of oesophagus

133.1

73.2

UJF92

NOMESCO Finland

Capsular endoscopy

6.7

73.2

117

179

G44.2

ICD-10 Finland

Tension-type headache

2.5

73.1

511

2217

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

11.6

72.5

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

71.6

767

4003

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

245.2

70.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

70.2

456

1907

N06AX21

ATC

duloxetine; oral

2.6

70.2

461

1939

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

69.9

529

2378

R51.80

ICD-10 Finland

Headache

2.4

68.5

555

2571

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

67.9

459

1955

N06AB04

ATC

citalopram; systemic

2.1

67.7

775

4139

R53

ICD-10 Finland

Malaise and fatigue

2.0

66.2

929

5344

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

65.7

384

1521

A06AD11

ATC

lactulose; oral

2.2

65.0

632

3159

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

16.8

63.4

N05BA01

ATC

diazepam; systemic, rectal

2.4

63.2

517

2399

N05BA04

ATC

oxazepam; oral

2.0

63.2

950

5585

J01DA01

ATC

[U] cefalexin

1.9

63.0

2079

15695

K22.7

ICD-10 Finland

Barrett oesophagus

24.0

62.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

62.8

374

1494

N06AA09

ATC

amitriptyline; systemic

2.6

62.8

389

1585

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.5

62.7

M54.5

ICD-10 Finland

Low back pain

1.9

62.2

1240

7995

N03AX12

ATC

[U] gabapentin; oral

2.2

62.2

603

3006

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

61.8

966

5747

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.9

61.7

110

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.5

60.7

219

656

N05CF01

ATC

zopiclone; oral

1.9

59.6

1166

7451

A02BX02

ATC

sucralfate; oral

3.7

59.2

194

545

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

155.3

58.1

J01MA02

ATC

ciprofloxacin; systemic

1.8

57.7

1366

9234

N06AX11

ATC

mirtazapine; oral

1.8

57.2

1166

7527

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

3.0

56.9

274

976

H02AB06

ATC

prednisolone; systemic

1.8

56.3

1620

11573

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

56.2

476

2235

1310

FHL

Esophagogastroscopy

21.8

55.2

R42

ICD-10 Finland

Dizziness and giddiness

1.9

55.1

863

5107

C01DA14

ATC

isosorbide mononitrate; oral

2.1

54.8

655

3525

XF402

NOMESCO Finland

ECG with work load test

2.4

54.6

400

1760

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

53.4

415

1875

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

52.9

253

897

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

52.5

781

4533

N05CD07

ATC

temazepam; oral

2.2

51.8

486

2377

R13

ICD-10 Finland

Dysphagia

2.9

51.4

265

979

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

51.1

509

2549

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.6

50.3

120

266

R12

ICD-10 Finland

Heartburn

2.7

49.7

278

1072

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.0

49.5

145

376

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

49.5

859

5228

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

20.2

49.5

K85

ICD-10 Finland

Acute pancreatitis

5.6

49.4

171

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

48.8

193

612

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

48.4

817

4924

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

48.3

619

3400

M79.6

ICD-10 Finland

Pain in limb

1.7

48.2

1430

10160

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.2

48.1

100

197

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

47.8

654

3674

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

47.5

374

1696

C07AB07

ATC

bisoprolol; oral

1.7

47.3

1706

12753

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

46.9

198

653

C07AB02

ATC

metoprolol; systemic

1.9

46.6

768

4587

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

45.9

1423

10188

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.8

45.9

246

927

R52.9

ICD-10 Finland

Pain, unspecified

2.3

45.8

370

1695

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

45.7

973

6275

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

45.2

982

6368

N05AH04

ATC

quetiapine; oral

2.0

44.8

579

3183

N06AX16

ATC

venlafaxine; oral

2.1

44.6

452

2271

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

44.6

624

3526

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

44.4

715

4231

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

44.3

756

4554

M03BX02

ATC

tizanidine; oral

1.7

44.3

1928

15030

N06AX03

ATC

mianserin; oral

3.0

44.2

201

692

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

44.0

282

1162

R03AC02

ATC

salbutamol; inhalant

1.7

43.9

1710

12944

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

43.9

1236

8599

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

43.7

266

1069

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

43.5

285

1187

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

43.5

276

1132

A01

ICPC

Pain general/multiple sites

2.3

43.4

375

1766

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

42.9

159

484

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

+∞

42.8

M01AB55

ATC

diclofenac, combinations; oral

2.6

42.7

265

1075

D01

ICPC

Abdominal pain/cramps general

2.2

42.6

394

1907

SPAT1263

SPAT

Sampling

1.7

42.6

1316

9363

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

42.5

453

2319

C03DA01

ATC

spironolactone; oral

2.1

42.1

479

2512

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

42.1

390

1890

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

41.7

654

3829

AA1AD

NOMESCO Finland

CT of head and brain

1.7

41.4

1022

6837

A07AA02

ATC

nystatin; oral

2.7

41.2

229

879

D02

ICPC

Abdominal pain epigastric

2.8

41.1

209

765

N05BA12

ATC

alprazolam; oral

2.3

41.1

358

1691

SPAT1254

SPAT

Administration of medicine

2.0

40.8

526

2881

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

40.8

1219

8570

J02AC01

ATC

fluconazole; systemic

1.7

40.8

1155

8007

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

+∞

40.7

N02AA05

ATC

oxycodone; systemic

1.8

40.4

688

4129

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.8

40.2

217

820

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.7

39.9

131

368

K86.1

ICD-10 Finland

Other chronic pancreatitis

8.1

39.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

39.7

611

3550

N03AE01

ATC

clonazepam; systemic

2.7

39.7

220

843

K59.0

ICD-10 Finland

Constipation

2.7

39.5

221

851

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

39.4

573

3267

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

39.4

364

1760

J01MA12

ATC

levofloxacin; systemic

1.9

39.3

635

3744

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

39.2

357

1716

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.8

38.9

122

332

J01FF01

ATC

clindamycin; systemic

1.7

38.9

876

5697

A02BDXX, ,

ATC

3.5

38.7

135

395

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

7.5

38.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

38.6

581

3349

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

38.4

263

1117

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.3

38.4

152

482

F10.24

ICD-10 Finland

Alcohol depence active use

5.5

38.3

140

K29.2

ICD-10 Finland

Alcoholic gastritis

197.3

37.9

A02BX

ATC

Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

5.7

37.8

124

I50.0

ICD-10 Finland

Congestive heart failure

2.2

37.8

331

1564

R10.0

ICD-10 Finland

Acute abdomen

3.4

37.6

138

417

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

+∞

37.6

J01AA02

ATC

doxycycline; systemic

1.7

37.5

2518

21465

M54.2

ICD-10 Finland

Cervicalgia

2.4

37.4

283

1257

A01AB04

ATC

amphotericin B; local oral

2.8

37.3

191

702

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

36.7

1088

7585

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

36.7

157

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

36.6

156

517

N06AB03

ATC

fluoxetine; oral

2.1

36.6

400

2061

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

+∞

36.5

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.2

36.3

147

K70.1

ICD-10 Finland

Alcoholic hepatitis

11.3

36.2

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

36.1

353

1743

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

361.2

36.0

N03AX09

ATC

lamotrigine; oral

3.1

35.6

155

520

A01AB09

ATC

miconazole; local oral

2.3

35.5

304

1422

M01AH02

ATC

rofecoxib; oral

2.0

35.2

438

2362

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

3.0

35.2

164

572

ZXD05

NOMESCO Finland

Urgent procedure

1.7

35.2

954

6490

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

35.0

420

2237

I20.09

ICD-10 Finland

Unstable angina

2.5

35.0

232

970

R03BB04

ATC

tiotropium bromide; inhalant

2.1

34.9

368

1869

A10AB05

ATC

insulin aspart; parenteral

2.3

34.8

286

1315

C10AC01

ATC

colestyramine; oral

3.8

34.8

106

283

J01DB01

ATC

cefalexin; oral

1.7

34.8

2608

22601

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

34.7

669

4144

N02BE01

ATC

paracetamol; systemic, rectal

1.9

34.7

2890

25819

SPAT1301

SPAT

No procedures

1.6

34.6

992

6837

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.9

34.4

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

34.0

278

1275

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

340.6

34.0

H02AB07

ATC

prednisone; oral

1.9

33.9

463

2575

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

33.9

293

1376

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

176.8

33.8

N07BB01

ATC

disulfiram; oral

3.0

33.7

149

504

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.1

33.6

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.3

33.6

131

Angiography of the heart and coronary arteries

2.4

33.5

244

1065

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.0

33.4

155

539

UJF02

NOMESCO Finland

Peroral enteroscopy

11.8

33.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

33.4

185

708

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

33.3

222

930

M01AH01

ATC

celecoxib; oral

1.8

33.1

595

3608

UKC02

NOMESCO Finland

Cystoscopy

1.8

33.0

563

3361

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

32.8

1374

10332

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

32.7

376

1969

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

32.7

1133

8156

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.6

32.5

174

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

9.6

32.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

32.3

689

4382

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.9

32.3

100

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.8

32.2

M48.0

ICD-10 Finland

Spinal stenosis

1.9

32.1

445

2485

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

32.0

118

358

SPAT1104

SPAT

Monitoring of emergency patient

2.4

31.9

237

1042

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

31.8

857

5795

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

12.0

31.6

J01FA06

ATC

roxithromycin; oral

1.6

31.5

1239

9161

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.7

31.3

100

276

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

4.7

31.3

159

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

31.3

A10AE04

ATC

insulin glargine; parenteral

2.1

31.2

342

1760

M79.7

ICD-10 Finland

Fibromyalgia

3.4

30.9

115

351

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

30.9

1362

10318

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

30.7

848

5760

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.8

30.5

244

N02AC04

ATC

dextropropoxyphene; oral

2.8

30.5

153

556

AN1

Coronary angiography

1.9

30.3

391

2129

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

30.3

918

6378

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

5.3

30.1

114

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

29.9

111

338

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

29.8

220

965

J01FA09

ATC

clarithromycin; systemic

1.6

29.8

899

6234

K22.2

ICD-10 Finland

Oesophageal obstruction

83.4

29.8

L04AX01

ATC

azathioprine; systemic

2.9

29.7

140

491

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.6

29.7

101

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

5.7

29.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

29.5

396

2184

N05BA02

ATC

chlordiazepoxide; systemic

3.5

29.5

102

297

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

29.5

551

3369

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

11.2

29.3

J01EA01

ATC

trimethoprim; systemic

1.6

29.3

826

5630

B01AC04

ATC

clopidogrel; oral

1.7

29.2

569

3518

M02AA07

ATC

piroxicam; topical

1.5

29.1

1147

8448

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

29.0

385

2115

M01AX17

ATC

nimesulide; oral

1.6

29.0

773

5194

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

29.0

184

753

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.5

29.0

157

R02

ICPC

Shortness of breath/dyspnoea

1.8

28.9

444

2559

M79.1

ICD-10 Finland

Myalgia

1.8

28.8

459

2674

S06.0

ICD-10 Finland

Concussion

2.0

28.8

353

1889

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

28.7

199

848

SPAT1285

SPAT

Provision of consultation response

2.5

28.7

189

787

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

28.6

149

552

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

28.5

401

2245

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

28.5

194

820

M25.5

ICD-10 Finland

Pain in joint

1.6

28.5

979

6986

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.1

28.4

120

C08CA05

ATC

nifedipine; systemic

2.3

28.4

230

1049

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

28.4

201

865

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

28.2

149

556

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

28.2

378

2084

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

28.0

1301

9904

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.7

28.0

141

Z50.1

ICD-10 Finland

Other physical therapy

2.4

27.8

191

811

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

283.9

27.8

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

27.8

189

799

C08CA01

ATC

amlodipine; oral

1.5

27.7

1290

9819

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.5

27.7

285

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

27.6

259

1255

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.4

27.6

101

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

27.5

615

3943

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

27.5

795

5439

R03BA02

ATC

budesonide; inhalant

1.7

27.5

547

3399

H02AB04

ATC

methylprednisolone; systemic

1.8

27.3

443

2592

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

27.3

231

1074

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

27.3

794

5441

A10AC01

ATC

insulin (human); parenteral

2.1

27.3

276

1377

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.9

27.2

204

SPAT1236

SPAT

Informing family of child’s disability

3.6

27.0

251

N06AB06

ATC

sertraline; oral

2.0

27.0

333

1784

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

27.0

229

1066

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

26.9

519

3195

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

26.9

235

1107

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

26.7

450

2663

L03

ICPC

Low back symptom/complaint

1.6

26.6

869

6111

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

26.6

273

1369

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

26.6

119

406

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.9

26.5

208

WX002

NOMESCO Finland

Sedation and analgesia

1.7

26.4

600

3859

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

26.4

195

855

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

26.4

129

462

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

26.4

227

1062

A07EA06

ATC

budesonide; oral, local oral

2.9

26.4

124

435

N03AF01

ATC

carbamazepine; oral, rectal

2.4

26.3

183

781

UJC12

NOMESCO Finland

Flexible oesophagoscopy

8.8

26.3

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.3

26.3

157

K55.8

ICD-10 Finland

Other vascular disorders of intestine

10.4

26.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

26.0

156

621

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.6

26.0

159

639

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

26.0

134

494

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.7

26.0

220

R52.2

ICD-10 Finland

Other chronic pain

2.8

26.0

135

500

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.5

25.9

A46

ICD-10 Finland

Erysipelas

1.7

25.9

511

3164

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

25.8

633

4153

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.6

1532

12205

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

25.6

680

4549

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

25.6

149

585

R07.0

ICD-10 Finland

Pain in throat

2.3

25.5

200

900

N06AA12

ATC

doxepin; systemic

2.4

25.5

180

774

N05AA02

ATC

levomepromazine; systemic

2.7

25.4

144

557

M01AE02

ATC

naproxen; oral, rectal

1.5

25.4

1656

13409

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

25.4

352

1959

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

25.4

779

5392

D06

ICPC

Abdominal pain localized other

2.1

25.3

267

1353

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

25.2

245

1203

J01DA09

ATC

[U] cefadroxil

1.6

25.2

784

5442

R03BA01

ATC

beclometasone; inhalant

1.8

25.1

438

2616

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

25.1

168

705

J01CA04

ATC

amoxicillin; systemic

1.5

25.1

2479

21789

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

25.0

2042

17252

M01AC06

ATC

meloxicam; systemic, rectal

1.5

25.0

1098

8215

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

24.9

168

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

24.8

256

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

24.7

425

2529

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

24.5

253

1271

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

24.4

125

459

C07AA05

ATC

propranolol; systemic

1.7

24.4

568

3671

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

24.4

213

1003

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

24.2

434

2612

A07EC02

ATC

mesalazine; oral, rectal

2.4

24.1

164

693

I20.00

ICD-10 Finland

Unstable angina

2.9

24.1

117

418

W19

ICD-10 Finland

Unspecified fall

1.9

24.0

336

1875

WZC00, ,

SPAT

1.7

24.0

459

2813

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

24.0

177

776

WX892

NOMESCO Finland

Monitored bed care

2.1

23.9

251

1268

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

23.9

249

1255

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.9

23.8

178

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

23.7

141

559

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

23.6

177

781

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

23.6

774

5425

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

23.6

1163

8880

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

23.5

173

757

P15

ICPC

Chronic alcohol abuse

3.1

23.4

100

332

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

5.3

23.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

23.4

234

1161

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

23.4

218

1053

M01AB05

ATC

diclofenac; systemic, rectal

1.5

23.4

2006

16999

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

23.3

106

365

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

23.3

570

3727

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

23.3

1177

9025

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

9.7

23.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

23.0

132

514

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

23.0

164

708

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

23.0

327

1833

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.5

23.0

149

616

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

22.9

374

2187

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

22.9

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.1

22.9

310

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.5

22.8

149

618

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

22.8

193

897

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

120.9

22.6

N06AB10

ATC

escitalopram; oral

1.6

22.6

555

3631

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

22.5

149

622

R51

ICD-10 Finland

Headache

2.4

22.4

157

672

M04AA01

ATC

allopurinol; systemic

1.7

22.4

451

2799

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.5

22.4

121

R04.2

ICD-10 Finland

Haemoptysis

2.7

22.4

126

486

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

22.4

853

6168

N02BF01

ATC

gabapentin; oral

1.9

22.3

321

1805

R03BA05

ATC

fluticasone; inhalant

1.7

22.3

518

3339

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

22.1

253

1319

A06AC51

ATC

ispaghula, combinations; oral

2.4

22.0

148

622

N05CF02

ATC

zolpidem; oral

1.7

22.0

510

3286

E87.6

ICD-10 Finland

Hypokalaemia

2.6

21.9

128

503

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

+∞

21.9

5355X

ICD-9 Finland

Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis

+∞

21.9

R55

ICD-10 Finland

Syncope and collapse

1.8

21.8

369

2180

N30.0

ICD-10 Finland

Acute cystitis

1.6

21.8

525

3414

C10AA01

ATC

simvastatin; oral

1.4

21.8

1346

10682

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

21.8

227

1144

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.5

21.7

120

R03DC03

ATC

montelukast; oral

1.7

21.7

464

2927

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

7.2

21.6

R06AE07

ATC

cetirizine; oral

1.4

21.6

1244

9744

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

21.5

497

3198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

21.4

197

946

G47.3

ICD-10 Finland

Sleep apnoea

1.6

21.3

671

4647

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

21.3

587

3942

J01MA14

ATC

moxifloxacin; systemic

1.9

21.1

287

1584

L17

ICPC

Foot/toe symptom/complaint

1.5

21.0

909

6731

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

21.0

174

802

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.5

20.9

138

575

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

20.9

168

764

205

Kela drug reimbursment

Chronic hypertension

1.5

20.9

908

6727

WZC30, ,

SPAT

1.9

20.8

281

1549

SPAT1058

SPAT

PEF monitoring instruction

2.0

20.8

245

1290

SPAT1097

SPAT

Recording of ECG

1.7

20.7

451

2855

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.9

20.7

329

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

20.7

728

5162

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.0

20.6

N02BF02

ATC

pregabalin; oral

2.1

20.6

212

1063

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

20.6

379

2293

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

20.5

303

1717

D11

ICPC

Diarrhoea

1.8

20.4

338

1984

D64.8

ICD-10 Finland

Other specified anaemias

3.3

20.2

234

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

20.2

101

367

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

48.3

20.1

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

20.1

739

5283

SPAT1260

SPAT

Consultation of another employee

1.6

20.1

515

3395

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.1

20.0

SPAT1240

SPAT

Therapeutic discussion

1.9

19.9

265

1452

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

19.9

237

1251

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

19.9

1560

12843

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.0

19.9

288

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

19.9

259

1410

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

19.9

359

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

19.8

509

3356

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.8

19.8

102

376

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

19.7

152

679

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

19.7

847

6248

P03

ICPC

Feeling depressed

1.9

19.7

244

1306

A02BX05

ATC

bismuth subcitrate; oral

4.0

19.6

143

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

19.6

717

5117

UJH02

NOMESCO Finland

Anoscopy

2.5

19.6

130

543

R01AD09

ATC

mometasone; nasal

1.4

19.6

1248

9904

R50.9

ICD-10 Finland

Fever, unspecified

1.6

19.6

455

2927

R00.2

ICD-10 Finland

Palpitations

2.0

19.6

228

1195

B80

ICPC

Iron deficiency anaemia

3.0

19.5

291

R01AD08

ATC

fluticasone; nasal

1.5

19.5

772

5599

A04

ICPC

Weakness/tiredness general

1.6

19.5

476

3099

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.9

19.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

19.4

549

3703

ZX120

NOMESCO Finland

Intravenous

1.8

19.4

288

1635

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

19.3

419

2648

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

19.3

122

499

F34.1

ICD-10 Finland

Dysthymia

2.7

19.2

106

405

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

15.6

19.2

R03BB01

ATC

ipratropium bromide; inhalant

2.3

19.2

142

623

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

19.2

245

1324

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

26.2

19.1

H01

ICPC

Ear pain/earache

1.8

19.1

313

1831

R03BA08

ATC

ciclesonide; inhalant

1.9

19.0

250

1365

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.6

18.8

113

451

B01AA03

ATC

warfarin; systemic

1.5

18.8

652

4600

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.7

18.7

101

382

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

18.7

451

2926

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

18.6

116

471

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

18.6

131

M01AX01

ATC

nabumetone; oral

2.3

18.6

138

607

SPAT1310

SPAT

Counselling related to known health issue

1.4

18.5

894

6732

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

18.5

254

1406

C09AA05

ATC

ramipril; oral

1.5

18.4

803

5928

Z01.3

ICD-10 Finland

Examination of blood pressure

3.7

18.4

159

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.8

18.4

150

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

18.4

265

1490

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

18.4

418

2673

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

18.3

212

1108

M02AA10

ATC

ketoprofen; topical

1.6

18.2

491

3270

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

18.2

234

1267

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

18.2

248

1369

M54

ICD-10 Finland

Dorsalgia

1.7

18.2

347

2117

L28

ICPC

Limited function/disability (L)

1.5

18.1

629

4432

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

18.1

805

5962

Z01.7

ICD-10 Finland

Laboratory examination

1.6

18.1

493

3292

S22.3

ICD-10 Finland

Fracture of rib

1.9

18.1

239

1307

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

18.1

391

2468

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

18.0

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

18.0

212

1115

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

17.9

1055

8224

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

17.9

118

492

A12BA01

ATC

potassium chloride; oral

2.1

17.9

166

800

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

17.8

234

1277

Z51.88

ICD-10 Finland

Other specified medical care

2.9

17.8

296

F45.0

ICD-10 Finland

Somatization disorder

13.7

17.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

17.7

227

1229

N05AB01

ATC

dixyrazine; systemic

4.2

17.7

114

D07AC01

ATC

betamethasone; topical

1.4

17.6

1072

8399

E000001, ,

ATC

1.5

17.6

554

3821

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

14.6

17.6

S18

ICPC

Laceration/cut

1.4

17.6

1423

11695

L01

ICPC

Neck symptom/complaint

1.6

17.6

449

2953

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.4

17.5

124

534

JAH01

NOMESCO Finland

Laparoscopy

2.3

17.5

131

578

K28.9

ICD-10 Finland

Gastrojejunal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

180.9

17.5

J01FA10

ATC

azithromycin; systemic

1.4

17.5

1559

13007

J46

ICD-10 Finland

Status asthmaticus

2.7

17.5

372

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

17.5

160

767

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.4

2043

17810

XJC10

NOMESCO Finland

Oesophageal pH monitoring

28.9

17.4

K10.3

ICD-10 Finland

Alveolitis of jaws

2.3

17.4

136

612

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

17.3

103

409

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

17.3

580

4053

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

17.3

226

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

17.3

150

705

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

17.2

146

679

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.3

17.2

191

T89

ICPC

Diabetes insulin dependent

2.4

17.2

122

526

N05BE01

ATC

buspirone; oral

2.8

17.2

324

R60.0

ICD-10 Finland

Localized oedema

1.6

17.2

401

2579

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.7

17.2

330

R06.4

ICD-10 Finland

Hyperventilation

3.9

17.1

130

C10AA05

ATC

atorvastatin; oral

1.4

17.1

1325

10794

N03AG01

ATC

valproic acid; systemic, rectal

2.1

17.1

176

882

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

17.0

203

1072

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.3

17.0

130

579

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

17.0

1050

8237

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

17.0

471

3155

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.0

17.0

122

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

17.0

409

2650

V03AA01, ,

ATC

3.6

17.0

154

E0000UV, ,

ATC

1.4

17.0

1193

9566

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

17.0

150

710

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

16.9

113

475

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

16.8

150

712

J01CA08

ATC

pivmecillinam; oral

1.4

16.8

1140

9082

A07AA09

ATC

vancomycin; oral

3.6

16.7

151

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

16.7

373

2372

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

16.7

1074

8481

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

16.7

341

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

16.6

388

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

16.6

116

497

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

16.6

1288

10483

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.6

587

4148

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

16.6

244

1381

6241

FHL

Fund application (Nissen)

170.8

16.5

H92.0

ICD-10 Finland

Otalgia

2.0

16.5

171

860

A10BA02

ATC

metformin; oral

1.4

16.5

890

6816

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

40.3

16.3

PD5AD

NOMESCO Finland

CT of aorta

2.7

16.3

311

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

16.3

274

1614

R52.0

ICD-10 Finland

Acute pain

2.5

16.2

102

417

Z00.8

ICD-10 Finland

Other general examinations

1.8

16.1

233

1310

K66.0

ICD-10 Finland

Peritoneal adhesions

6.8

16.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

16.1

198

1057

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

30.2

16.1

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

16.0

395

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

16.0

242

1380

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

47.7

16.0

Z2446

NOMESCO Finland

Social worker

2.0

16.0

183

953

K50.8

ICD-10 Finland

Other Crohn disease

4.0

16.0

114

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

16.0

252

1455

A10AE05

ATC

insulin detemir; parenteral

2.0

16.0

165

829

R35

ICD-10 Finland

Polyuria

1.9

15.9

218

1205

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

15.9

133

615

A10AB01

ATC

insulin (human); parenteral

2.4

15.9

108

457

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

15.9

281

J45

ICD-10 Finland

Asthma

1.7

15.9

289

1740

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

15.9

183

956

B01AB05

ATC

enoxaparin; parenteral

1.4

15.8

932

7236

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

15.8

316

1952

M54.1

ICD-10 Finland

Radiculopathy

2.2

15.7

126

573

R03AC03

ATC

terbutaline; inhalant

1.6

15.7

384

2496

J01DA06

ATC

[U] cefuroxime

1.6

15.7

401

2634

N06AB05

ATC

paroxetine; oral

2.0

15.6

165

835

H25.8

ICD-10 Finland

Other senile cataract

1.6

15.6

369

2377

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

+∞

15.6

N05AF03

ATC

chlorprothixene; systemic

2.8

15.6

295

C05AA08

ATC

fluocortolone; rectal, topical

1.6

15.6

385

2507

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

15.6

663

4852

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.4

15.6

104

437

N07BA03

ATC

varenicline; oral

2.2

15.6

136

641

Catheterization and pressure measurement of the left side of the heart

3.1

15.5

204

K22.0

ICD-10 Finland

Achalasia of cardia

160.7

15.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

15.5

227

1283

K70.0

ICD-10 Finland

Alcoholic fatty liver

5.0

15.5

R07.2

ICD-10 Finland

Precordial pain

2.8

15.4

280

R05

ICD-10 Finland

Cough

1.5

15.4

595

4275

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

15.4

316

1966

R96

ICPC

Asthma

1.7

15.3

286

1734

WX704

NOMESCO Finland

Intubation

1.8

15.3

240

1385

SPAT1255

SPAT

Intravenous administration of medicine

1.9

15.3

212

1178

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

15.3

1187

9630

K70.4

ICD-10 Finland

Alcoholic hepatic failure

11.3

15.2

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

15.2

260

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

3.4

15.2

156

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

15.1

283

107

Kela drug reimbursment

Pernicious anaemia

3.1

15.1

207

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

15.1

318

1990

C10AA03

ATC

pravastatin; oral

1.8

15.1

221

1248

XJ110

NOMESCO Finland

Respiratory helicobactery test

20.1

15.1

K08.3

ICD-10 Finland

Retained dental root

1.8

15.1

240

1390

SPAT1262

SPAT

Handing over of treatment supplies

1.5

15.0

510

3565

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

15.0

291

1781

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.0

15.0

106

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

15.0

265

1582

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

15.0

2061

18197

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

3.9

14.9

111

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

14.9

274

R51.81

ICD-10 Finland

Facial pain NOS

2.8

14.9

280

J20

ICD-10 Finland

Acute bronchitis

1.7

14.9

292

1794

A03DA02

ATC

pitofenone and analgesics; systemic

2.8

14.8

258

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

14.8

286

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

14.8

384

2528

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

14.8

428

2890

T90

ICPC

Diabetes non-insulin dependent

1.4

14.8

740

5574

L04AD01

ATC

ciclosporin; systemic

3.2

14.8

184

R33

ICD-10 Finland

Retention of urine

1.7

14.8

259

1543

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

14.7

330

2097

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

14.7

179

952

A10AB04

ATC

insulin lispro; parenteral

2.5

14.7

369

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

14.7

322

E86

ICD-10 Finland

Volume depletion

2.5

14.6

352

A01AB10

ATC

natamycin; local oral

2.5

14.6

376

J01MA06

ATC

norfloxacin; oral

1.6

14.6

383

2528

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

14.6

277

S01BC05

ATC

ketorolac; ophthalmic

2.1

14.6

137

664

A11CC03

ATC

alfacalcidol; systemic

2.6

14.6

312

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

14.5

129

612

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

14.5

260

1558

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

14.5

109

483

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

14.5

163

845

P01

ICPC

Feeling anxious/nervous/tense

1.7

14.5

262

1575

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.1

14.4

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

14.4

262

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

14.4

267

1615

L02

ICPC

Back symptom/complaint

1.7

14.3

274

1671

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

14.3

188

1026

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.0

14.3

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.3

14.2

105

462

ZXA00

NOMESCO Finland

Right side

1.4

14.2

782

5985

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

14.1

139

N01

ICPC

Headache

1.7

14.1

255

1531

Z72.1

ICD-10 Finland

Alcohol use

3.8

14.1

111

N06AA04

ATC

clomipramine; systemic

3.2

14.1

169

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.1

14.1

195

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

14.0

110

496

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

14.0

153

784

K08.80

ICD-10 Finland

Toothache NOS

1.8

14.0

229

1336

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

14.0

383

2554

N04BC05

ATC

pramipexole; oral

1.8

13.9

223

1294

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

13.9

223

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

13.9

286

1779

M01AH05

ATC

etoricoxib; oral

1.3

13.9

1772

15391

SPAT1312

SPAT

General health counselling

1.4

13.9

836

6491

K85.8

ICD-10 Finland

Other acute pancreatitis

5.0

13.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

13.8

180

980

SPAT1153

SPAT

Removal of sutures

1.4

13.8

902

7094

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

13.8

209

1193

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.0

13.8

IHZ05, ,

SPAT

2.4

13.8

387

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

4.7

13.8

JKA20

NOMESCO Finland

Cholecystectomy

2.4

13.7

394

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

13.7

306

1944

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

13.7

326

2104

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

13.6

420

A11

ICPC

Chest pain NOS

1.7

13.6

245

1470

E87.5

ICD-10 Finland

Hyperkalaemia

2.8

13.6

254

J01MA01

ATC

ofloxacin; systemic

1.7

13.5

244

1464

L99

ICPC

Musculoskeletal disease other

2.7

13.5

283

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

13.5

157

824

M10.9

ICD-10 Finland

Gout, unspecified

1.8

13.4

219

1277

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

13.4

319

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.4

13.4

398

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

13.4

149

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

13.4

228

TK800

NOMESCO Finland

Hemodialysis

2.8

13.3

245

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

13.3

351

R21

ICPC

Throat symptom/complaint

1.5

13.3

471

3319

G04CA02

ATC

tamsulosin; oral

1.4

13.2

710

5401

L50.0

ICD-10 Finland

Allergic urticaria

2.6

13.2

292

N06AG02

ATC

moclobemide; oral

2.1

13.2

123

595

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

13.2

172

937

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

13.2

108

497

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

13.2

101

452

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

13.1

147

762

SPAT1241

SPAT

Extensive assessment of psychosocial situation

4.5

13.1

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.5

13.1

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.0

1500

12798

B82

ICPC

Anaemia other/unspecified

2.3

13.0

404

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

13.0

117

559

M54.8

ICD-10 Finland

Other dorsalgia

2.1

13.0

128

633

R04

ICPC

Breathing problem other

2.1

13.0

121

586

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

12.9

343

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.3

12.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.6

12.9

284

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

12.8

444

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

12.8

195

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

12.8

169

924

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

12.8

256

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

12.8

363

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.7

12.8

105

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

12.8

291

R25.2

ICD-10 Finland

Cramp and spasm

2.6

12.8

297

KMAK, ,

NOMESCO Finland

1.3

12.8

1362

11487

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

12.8

193

1101

C08DA01

ATC

verapamil; systemic

2.0

12.8

135

685

N03AF02

ATC

oxcarbazepine; oral

2.3

12.7

414

A10AA01, ,

ATC

2.5

12.7

310

S80.0

ICD-10 Finland

Contusion of knee

1.8

12.7

207

1208

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

5.1

12.7

D12

ICPC

Constipation

2.1

12.7

116

558

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

12.6

434

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

12.6

189

1075

I86.4

ICD-10 Finland

Gastric varices

70.1

12.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

12.6

648

4890

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.6

12.5

288

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

12.5

288

5354X

ICD-9 Finland

Gastritis and duodenitis, Other specified gastritis

+∞

12.5

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

860

2449

4.39

274.19

1.4

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1615

8307

2.84

186.17

3.9

2.4

54.13

59.77

u/l

3.93

1501

7670

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2132

14533

2.31

111.70

8.2

6.4

11.20

11.95

umol/l

1.48

2055

13861

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1250

7253

2.16

92.87

3.3

2.2

3.32

2.84

mg/l

8.01

1120

6216

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1660

10790

2.08

90.58

5.9

3.7

35.29

103.69

ng/l

1.02

1275

7860

(3006315) Basophils [#/volume] in Blood

1914

13832

1.91

69.53

8.0

6.1

0.04

e9/l

0.06

1715

11722

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1370

8893

1.92

69.20

2.6

2.1

182.52

211.02

u/l

0.70

1307

8367

(3024561) Albumin [Mass/volume] in Serum or Plasma

1804

12802

1.90

69.19

6.7

4.9

34.87

35.36

g/l

3.11

1713

11969

(3048689) Calprotectin [Mass/mass] in Stool

609

2929

2.32

69.02

2.9

2.2

164.93

149.92

ug/g

0.38

523

2323

(3022948) Iron [Moles/volume] in Serum or Plasma

863

4787

2.08

68.30

3.4

2.5

12.29

12.79

umol/l

0.86

807

4458

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1818

12985

1.88

67.79

8.6

6.4

1.20

1.21

mmol/l

6.51

1710

11980

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1982

14555

1.90

67.74

9.2

7.0

1.21

mmol/l

4.93

1762

12493

(3001604) Monocytes [#/volume] in Blood

1903

13802

1.89

67.52

8.0

6.0

0.60

0.59

e9/l

0.56

1709

11692

(3013115) Eosinophils [#/volume] in Blood

1952

14285

1.89

67.21

8.2

6.2

0.20

0.19

e9/l

1.89

1761

12277

(3032080) INR in Blood by Coagulation assay

1857

13388

1.88

66.87

21.5

16.3

1.32

1.30

inr

0.73

1575

11208

(3019198) Lymphocytes [#/volume] in Blood

1929

14100

1.88

66.25

8.1

6.1

1.87

1.91

e9/l

0.31

1761

12226

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

996

5925

1.97

64.19

1.9

1.7

1.19

1.33

mg/l

0.67

781

4638

(3004789) Transferrin [Mass/volume] in Serum or Plasma

808

4463

2.07

64.13

3.3

2.5

2.39

2.27

g/l

7.73

753

4129

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

760

4133

2.09

62.73

3.3

2.6

21.23

22.41

1.40

713

3835

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1720

12258

1.84

62.67

4.4

2.9

123.41

137.33

ug/l

1.05

1626

11402

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

335

1268

2.83

62.42

2.7

2.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2169

16625

1.88

62.28

7.2

4.9

6.94

6.75

mmol/l

3.51

2080

15822

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

449

1976

2.47

61.68

2.1

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2072

15709

1.85

60.97

10.8

9.5

4.28

4.17

e9/l

1.39

1866

13469

(3019150) Specific gravity of Urine by Refractometry

1047

6426

1.92

60.91

6.1

4.1

1.02

1.25

kg/l

0.50

738

4284

(3019309) Folate [Moles/volume] in Red Blood Cells

845

4859

1.99

59.32

2.0

1.8

1245.57

1175.08

nmol/l

1.25

685

3638

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1336

8980

1.82

57.45

3.8

3.2

2055.12

1607.66

ng/l

1.16

1172

7787

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1328

8920

1.81

57.16

4.3

3.1

34.34

37.86

u/l

0.76

1247

8415

(3023368) Bacteria identified in Blood by Culture

1250

8250

1.83

56.97

5.3

4.3

—

(3037522) Nuclear Ab [Titer] in Serum

656

3487

2.10

56.94

1.4

1.3

675.80

529.21

titre

0.90

143

738

(3015736) pH of Urine

1632

11680

1.78

56.44

5.0

3.4

6.34

6.23

3.87

1010

6424

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2585

21278

1.97

56.08

11.6

7.9

80.49

80.43

u/l

0.02

2485

20131

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2483

20189

1.91

55.60

6.2

4.1

13.94

12.93

mm/h

2.66

2333

18816

(3012544) pH of Venous blood

582

3003

2.14

54.39

4.9

3.4

7.37

7.38

0.68

334

1696

(3003396) Base excess in Arterial blood by calculation

639

3442

2.06

53.16

6.8

7.5

1.20

1.00

mmol/l

0.57

532

2833

(3019977) pH of Arterial blood

640

3459

2.05

52.71

7.0

7.6

7.41

7.42

0.32

389

1864

(3027801) Oxygen [Partial pressure] in Arterial blood

640

3469

2.05

52.25

6.9

7.6

11.50

12.28

kpa

3.57

618

3334

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

640

3470

2.05

52.20

6.9

7.6

5.12

5.10

kpa

0.13

619

3338

(3002032) Base excess in Venous blood by calculation

559

2882

2.13

52.17

4.9

3.4

1.83

mmol/l

0.00

501

2495

(3031040) Bacteria [#/volume] in Urine by Automated count

2276

18169

1.80

52.04

6.8

4.7

5375.96

1815.63

e6/l

0.45

268

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1711

12610

1.74

51.68

2.5

2.1

93.90

95.10

pmol/l

0.46

982

6539

(3000570) Elastase.pancreatic [Mass/mass] in Stool

218

721

3.17

51.43

1.6

1.4

270.08

274.35

ug/g

0.11

130

429

(3019060) Gas panel - Arterial blood

388

1757

2.37

49.50

5.4

4.4

—

(3023520) Reticulocytes [#/volume] in Blood

509

2585

2.14

49.18

3.0

2.6

73.72

67.54

e9/l

3.00

410

1853

(3016502) Oxygen saturation in Arterial blood

577

3075

2.06

49.06

7.1

7.9

95.17

95.53

0.63

560

2974

(3021447) Carbon dioxide [Partial pressure] in Venous blood

564

2983

2.07

48.94

5.0

3.3

5.87

5.81

kpa

0.63

548

2893

(3027945) Reticulocytes/Erythrocytes in Blood

610

3329

2.02

48.53

2.6

2.5

1.99

1.77

4.55

545

2964

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

896

5560

1.84

48.35

1.4

1.3

2.51

1.74

u/ml

0.50

260

1510

(3008152) Bicarbonate [Moles/volume] in Arterial blood

394

1827

2.31

47.50

8.4

6.3

24.79

24.51

mmol/l

0.65

386

1748

(3013139) Helicobacter pylori Ag [Presence] in Stool

336

1466

2.44

46.47

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

492

2517

2.12

46.47

4.4

2.8

4.29

4.52

kpa

2.21

480

2438

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

560

3021

2.03

45.78

3.3

2.6

8.08

9.09

umol/l

0.51

493

2657

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

480

2469

2.10

44.57

2.8

2.3

4.81

7.70

ug/l

5.02

414

2171

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

727

2.99

44.53

1.6

19.75

16.75

u/ml

0.21

165

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

335

1489

2.39

44.39

5.9

3.6

47.67

47.40

0.07

330

1459

(3026008) Bacteria identified in Urine by Culture

1264

8855

1.69

43.65

4.1

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1188

8256

1.68

41.85

2.0

1.7

19.75

20.19

nmol/l

0.43

1045

6978

(3006504) Eosinophils/Leukocytes in Blood

1673

12694

1.64

41.72

8.4

6.3

2.92

2.82

0.95

1572

11880

(3000850) Epithelial cells [#/volume] in Urine

988

6550

1.72

41.36

3.5

2.6

5.48

5.54

e6/l

0.05

932

5969

(3020779) Urea [Moles/volume] in Serum or Plasma

485

2577

2.03

41.03

8.5

6.9

10.86

10.44

mmol/l

0.57

466

2459

(3019069) Monocytes/Leukocytes in Blood

1667

12726

1.62

39.86

8.5

6.4

8.94

8.97

0.20

1570

11914

(3022096) Basophils/Leukocytes in Blood

1661

12691

1.62

39.41

8.6

6.4

0.69

0.67

0.89

1564

11866

(3035350) Ketones [Presence] in Urine by Test strip

1878

14788

1.62

39.32

5.7

3.9

7.23

3.97

estimate

0.27

352

3255

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1672

12803

1.62

39.25

3.7

2.7

—

estimate

—

(3018010) Neutrophils/Leukocytes in Blood

1661

12707

1.61

39.08

8.2

6.2

58.35

57.92

0.75

1586

12137

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1480

11020

1.62

38.85

5.8

3.9

0.02

0.26

estimate

0.66

287

2590

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

907

5963

1.72

38.67

1.9

1.7

444.07

29407400.61

pmol/l

4.35

762

4907

(3002173) Hemoglobin [Mass/volume] in Arterial blood

519

2881

1.95

38.59

7.7

8.4

119.69

121.34

g/l

0.98

512

2817

(3003458) Phosphate [Moles/volume] in Serum or Plasma

627

3715

1.85

38.11

7.2

5.7

1.04

mmol/l

0.06

587

3431

(40761535) Cells panel - Urine sediment

420

2172

2.07

38.10

4.4

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1853

14616

1.61

37.91

5.7

3.9

0.00

estimate

0.42

350

3154

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

296

1334

2.34

37.83

1.6

1.7

1.49

1.56

g/l

0.63

257

1141

(3009261) Glucose [Presence] in Urine by Test strip

1881

14901

1.61

37.70

5.9

3.9

0.01

0.11

estimate

0.50

333

3041

(3012095) Magnesium [Moles/volume] in Serum or Plasma

758

4768

1.76

37.68

3.8

3.2

0.80

0.82

mmol/l

2.88

719

4466

(3004119) Hemoglobin [Mass/volume] in Venous blood

372

1846

2.14

37.60

4.1

2.9

126.65

129.26

g/l

1.37

356

1789

(3027273) Bicarbonate [Moles/volume] in Venous blood

292

1312

2.34

37.58

4.8

3.0

25.13

25.25

mmol/l

0.26

281

1259

(3002030) Lymphocytes/Leukocytes in Blood

1680

12986

1.59

37.11

8.4

6.3

26.53

27.05

1.13

1599

12284

(42870588) Differential panel, method unspecified - Blood

1269

9180

1.62

36.97

7.6

6.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

555

3194

1.89

36.87

2.1

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

782

4995

1.74

36.71

2.3

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

768

4890

1.74

36.42

1.6

1.5

2.71

2.48

g/l

1.94

504

2963

(3042936) Bacteria identified in Isolate by Culture

655

3989

1.80

36.19

2.6

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

1237

8934

1.61

36.03

3.3

2.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2136

17546

1.61

35.92

4.8

3.1

61.12

50.37

u/l

3.62

2012

16360

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

572

3352

1.85

35.81

4.2

4.6

233.39

251.35

u/l

2.60

538

3181

(3025941) Bacteria identified in Stool by Culture

284

1304

2.29

34.68

1.4

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1345

9991

1.58

34.33

3.1

3.6

2.34

2.36

mmol/l

5.35

1217

9095

(3036481) Cortisol [Moles/volume] in Serum or Plasma

448

2459

1.95

34.16

2.4

2.2

370.38

385.43

nmol/l

0.95

414

2275

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

310

1494

2.19

33.62

1.7

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

383

2004

2.03

33.45

1.6

1.4

—

(3022145) Colonoscopy Study observation

498

2854

1.88

33.26

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

153

538

2.93

32.35

3.4

2.3

33.47

35.71

umol/l

0.35

145

482

(3026493) Urate [Moles/volume] in Serum or Plasma

1036

7320

1.60

32.21

3.4

2.8

352.10

347.61

umol/l

0.62

909

6422

(40760892) CBC W Ordered Manual Differential panel - Blood

876

5955

1.64

31.82

6.7

4.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

461

2624

1.88

31.33

6.2

7.6

1.48

1.31

mmol/l

1.54

451

2580

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

602

3732

1.75

30.79

2.2

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1601

12588

1.53

30.39

2.9

2.3

76.73

78.62

nmol/l

1.97

1449

11336

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

206

870

2.46

30.34

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

969

6826

1.59

30.11

5.3

3.7

0.42

0.11

0.57

(3020630) Protein [Mass/volume] in Serum or Plasma

441

2516

1.87

29.66

2.5

2.8

66.23

66.16

g/l

0.07

402

2297

(3007566) Smooth muscle Ab [Titer] in Serum

170

663

2.65

29.54

1.3

1.2

110.00

102.83

titre

0.10

(3002582) Erythrocytes [#/volume] in Urine

1260

9460

1.54

29.33

4.5

3.3

48.90

79.41

e6/l

0.98

1052

7213

(3005719) IgG [Mass/volume] in Serum or Plasma

365

1966

1.96

29.19

3.1

2.9

10.54

10.57

g/l

0.05

336

1809

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

684

4465

1.67

28.72

1.4

1.3

10.18

11.93

u/ml

0.27

288

1771

(3018418) pH of Serum or Plasma

1196

8921

1.53

28.47

5.4

4.1

7.40

1.45

890

6358

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

459

2692

1.82

28.16

2.6

2.0

0.19

0.21

g/l

3.03

423

2508

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

952

6774

1.57

27.92

3.1

2.3

—

(3000991) Gas panel - Venous blood

433

2501

1.84

27.91

7.7

8.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

718

4782

1.64

27.75

1.4

1.3

24.86

32.77

iu/ml

1.33

242

1429

(3018405) Lactate [Moles/volume] in Arterial blood

214

958

2.32

27.64

5.3

3.6

1.31

1.37

mmol/l

0.56

214

944

(3030467) Casts [#/volume] in Urine by Automated count

1108

8170

1.53

27.62

4.3

3.2

0.37

0.45

e6/l

0.52

897

6019

(3017143) Hepatitis C virus Ab [Presence] in Serum

446

2624

1.81

27.02

1.7

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

562

3535

1.71

26.96

2.2

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

815

5633

1.59

26.94

5.8

3.8

156.73

594.66

ng/l

2.01

643

4594

(3017315) Amylase [Enzymatic activity/volume] in Urine

104

5.26

26.72

1.4

1.2

336.31

259.52

u/l

0.16

(3029937) Albumin [Presence] in Urine by Test strip

1108

8219

1.52

26.63

5.9

4.1

0.00

estimate

1.54

309

2874

(3028026) IgM [Mass/volume] in Serum or Plasma

296

1529

2.03

26.59

1.9

2.0

1.38

1.39

g/l

0.03

271

1397

(36304419) Bacteria [Presence] in Urine

1051

7770

1.52

25.40

4.2

3.1

111.53

72.86

estimate

0.12

(3018095) Leukocytes [#/volume] in Urine

1367

10662

1.48

25.40

5.0

3.9

79.39

109.10

e6/l

0.98

1078

7535

(3026389) Candida sp identified in Specimen by Organism specific culture

101

323

3.19

25.19

1.7

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

662

4420

1.62

25.03

2.3

2.1

29.66

29.77

0.19

640

4300

(3013512) EKG study

1262

9714

1.48

24.92

5.4

3.5

0.80

0.76

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

430

2568

1.77

24.64

3.6

2.4

36.36

39.05

u/l

0.31

362

2159

(3026782) Osmolality of Urine

793

5589

1.55

23.60

4.0

2.8

513.77

535.00

mosm/kgh2o

2.11

717

4890

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

241

1206

2.08

23.55

2.2

1.9

2.12

2.38

ug/l

0.14

222

1061

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

628

2.49

23.46

2.3

180.36

103.72

ug/min

0.94

365

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2368

20726

1.50

23.35

5.4

4.3

15.00

14.87

pmol/l

1.79

2208

18931

(44816559) Phosphatidylethanol [Mass/volume] in Blood

208

987

2.18

23.32

2.3

1.6

0.40

0.30

mg/l

1.57

454

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

321

1795

1.87

22.74

4.7

3.5

5.20

5.17

kpa

0.29

299

1704

(3009343) pH of Capillary blood

313

1737

1.89

22.71

4.7

3.6

7.42

0.09

266

1413

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

277

1499

1.93

21.67

4.6

3.5

2.20

2.02

mmol/l

0.30

208

1085

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

368

2178

1.78

21.62

4.5

3.8

99.14

91.99

ng/l

0.67

313

1846

(3030981) Hyaline casts [#/volume] in Urine by Automated count

391

2356

1.75

21.59

2.7

2.5

0.57

0.51

e6/l

0.17

375

2252

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

380

2283

1.75

21.18

2.9

2.7

63.24

65.39

ml/min/173m2

0.54

189

975

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

719

5078

1.53

20.84

3.4

3.0

1.05

1.16

e6/l

0.35

457

2702

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

195

943

2.13

20.84

1.3

—

(3000494) Fungus identified in Specimen by Culture

497

3240

1.63

20.33

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

168

773

2.24

20.33

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

567

3840

1.57

19.72

1.7

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

149

661

2.31

19.66

1.4

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

308

1779

1.81

19.59

6.9

9.7

24.38

24.35

mmol/l

0.05

297

1739

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

445

2851

1.65

19.46

2.3

1.7

1.65

1.48

3.39

380

2486

(3014765) Yersinia sp identified in Stool by Organism specific culture

148

665

2.28

18.96

1.4

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

145

650

2.29

18.68

1.7

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

502

3344

1.59

18.67

13.2

6.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

194

981

2.04

18.42

3.5

2.9

24.98

24.81

mmol/l

0.20

188

965

(42529406) Shigella sp [Presence] in Stool by Culture

147

672

2.24

18.08

1.4

1.2

—

(3017732) Neutrophils [#/volume] in Blood

498

3337

1.58

18.01

4.9

3.2

5.17

4.77

e9/l

0.22

420

2880

(40758558) Short blood count panel - Blood

1069

8352

1.41

17.95

7.1

6.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

7.27

17.80

1.1

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

155

729

2.18

17.79

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1212

9735

1.39

17.08

4.5

4.1

10.56

8.51

mg/mmol

0.82

804

6092

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

974

2.00

17.03

1.3

1.2

1.02

0.99

u/ml

0.02

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

490

3313

1.56

16.98

1.7

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

198

1039

1.96

16.94

2.0

1.8

7.33

7.42

iu/ml

0.02

249

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

101

4.30

16.88

1.9

2.3

100.00

147.43

umol/l

0.44

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

186

959

2.00

16.73

2.9

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

191

3.29

16.53

1.5

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

265

1540

1.78

16.47

1.4

1.3

266.85

229.98

u/ml

0.27

243

1427

(3006184) Hemoglobin [Mass/volume] in Capillary blood

141

660

2.19

16.39

3.0

2.2

126.77

129.10

g/l

0.38

108

522

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

795

5978

1.43

16.25

2.8

3.1

2.44

2.46

mmol/l

3.54

702

5405

(3014051) Protein [Presence] in Urine by Test strip

982

7666

1.40

16.21

4.1

2.9

0.04

0.05

0.10

221

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

1237

1.86

16.13

6.5

4.9

0.88

0.03

216

1167

(3012516) Albumin [Mass/volume] in Urine

1186

9566

1.37

16.02

3.9

3.4

53.99

44.27

mg/l

0.95

818

6183

(3000093) Morphology [Interpretation] in Blood Narrative

243

2.96

15.88

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

525

2.29

15.52

8.5

4.8

641.40

4074.03

iu/ml

0.53

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

237

1358

1.80

15.44

6.3

4.7

1.67

1.59

0.65

229

1283

(3009508) Creatinine [Moles/volume] in Urine

1222

9946

1.36

15.43

3.8

3.4

7.30

7.43

mmol/l

0.49

1042

8410

(3020191) Ethanol [Moles/volume] in Serum or Plasma

190

3.20

15.32

2.7

1.4

1.52

1.18

promille

0.83

152

(3034860) Kappa light chains.free [Mass/volume] in Serum

192

1035

1.91

15.18

3.0

3.7

49.46

53.71

mg/l

0.31

164

885

(3033658) Prothrombin time (PT) actual/Normal

910

7089

1.39

14.99

6.1

3.9

86.61

88.40

1.26

881

6939

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

191

1033

1.90

14.95

3.0

3.7

46.23

53.24

mg/l

0.24

163

886

(3019225) pH of Specimen

393

2599

1.58

14.90

5.0

4.4

7.34

7.35

0.33

302

1855

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2856

26662

1.51

14.76

28.7

16.0

22.80

25.94

mg/l

6.58

2562

22035

(3000330) Specific gravity of Urine by Test strip

245

1444

1.75

14.50

4.5

3.2

1.02

ratio

0.63

220

1313

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

145

721

2.06

14.45

1.3

1.2

28.80

46.99

u/ml

0.43

(46235355) HIV 1 and 2 tests - Meaningful Use set

541

3858

1.48

14.42

1.9

1.7

—

(3047181) Lactate [Moles/volume] in Blood

164

853

1.97

14.41

6.7

5.6

1.49

1.31

mmol/l

1.14

145

756

(3004775) Volume in Urine collected for unspecified duration

203

3.04

14.36

2.4

2.2

587.63

628.74

0.34

125

(3022313) Gas panel - Capillary blood

211

1196

1.82

14.25

4.9

3.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

191

1053

1.86

14.10

2.1

2.3

308.32

519.62

ug/l

1.35

184

1000

(40760888) Immunoglobulin light chains.free panel - Serum

137

674

2.08

14.05

3.4

4.0

—

(3016750) Collection duration of Urine

145

3.41

13.96

2.0

2.1

505.02

488.55

min

0.64

100

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

141

3.44

13.84

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

171

916

1.91

13.79

3.0

3.6

1.71

3.88

ratio

1.27

104

531

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

1061

1.85

13.77

1.8

2.5

10.40

10.33

g/l

0.08

164

943

(36660697) Celiac disease serology panel - Serum

304

1928

1.63

13.68

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

275

1700

1.67

13.67

9.3

10.0

15.66

16.01

1.29

268

1637

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.45

13.52

2.8

2.4

5.04

129.62

ug/l

0.78

(3006270) Folate [Moles/volume] in Blood

201

2.97

13.35

1.4

1.1

298.88

377.90

nmol/l

2.11

170

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

135

675

2.04

13.27

1.3

1.2

3.72

2.45

u/ml

0.66

(3038177) Helicobacter pylori Ab [Presence] in Serum

316

2.54

13.18

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

211

1227

1.77

13.08

2.0

2.5

3.72

3.75

g/l

0.14

187

1119

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

134

672

2.04

13.07

1.3

3.51

10.08

u/ml

1.26

102

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

211

1228

1.77

13.05

2.0

2.5

7.54

7.49

g/l

0.14

188

1120

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1228

1.76

12.78

2.0

2.5

4.29

4.20

g/l

0.84

187

1120

(3028707) Methadone [Presence] in Urine by Screen method

264

2.65

12.61

3.1

2.4

—

(4034850) Laboratory test

162

879

1.89

12.59

16.9

10.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

140

3.32

12.58

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

560

2.11

12.54

1.1

5.49

5.82

eliau/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

325

2.47

12.44

1.1

1.61

1.50

g/l

1.50

298

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2670

24803

1.39

12.39

6.7

5.2

1.91

1.95

mu/l

0.71

2504

22796

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.77

12.12

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

568

2.08

12.09

1.3

1.2

2.58

2.42

u/ml

0.04

(3045414) Leukocytes [Presence] in Urine

382

2641

1.50

11.74

2.2

2.1

0.00

0.01

estimate

0.78

545

(3003181) Sodium [Moles/volume] in Urine

108

523

2.10

11.60

1.6

1.3

56.41

59.93

mmol/l

0.43

418

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

417

2.22

11.25

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

160

897

1.82

11.24

5.1

3.9

24.97

24.86

mmol/l

0.15

144

805

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1742

15349

1.28

11.13

3.1

2.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

421

3001

1.46

11.08

3.1

4.3

7.64

20.11

ug/l

2.62

355

2455

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

175

1013

1.77

11.05

2.8

3.5

1194.78

4982.88

u/ml

0.73

155

874

(40757494) Bilirubin.total [Moles/volume] in Blood

127

3.26

10.94

2.2

2.1

47.27

16.00

umol/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

347

2389

1.51

10.86

4.2

3.0

230.95

216.67

ng/l

0.25

326

2198

(3037756) Immunofixation for Serum or Plasma

121

627

1.97

10.82

1.7

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

294

2.41

10.60

1.8

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

138

755

1.86

10.50

2.1

1.7

0.24

g/l

0.20

132

723

(3004716) Salmonella sp identified in Stool by Organism specific culture

182

1082

1.72

10.48

1.7

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

254

2.51

10.41

1.3

63447.72

59389.81

e6/l

0.03

170

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

426

2.14

10.29

3.2

2.5

272.00

1769.73

u/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

106

534

2.02

10.28

1.2

50.25

45.60

u/ml

0.11

(3017181) Myelocytes/Leukocytes in Blood

369

2603

1.47

10.23

5.2

4.2

1.18

0.89

0.98

135

791

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.82

10.20

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.57

10.19

3.8

2.1

720.62

864.94

e6/l

0.14

(3028626) Oxygen [Partial pressure] in Capillary blood

129

698

1.88

10.16

3.8

3.0

7.88

7.96

kpa

0.22

122

683

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

483

2.06

10.10

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

140

781

1.83

10.02

2.1

1.6

1.22

1.21

g/l

0.21

135

748

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

195

2.69

9.95

1.1

293.49

291.70

mg/l

0.07

179

(3020876) Protein [Mass/time] in 24 hour Urine

348

2.24

9.88

2.5

2.3

1.12

1.34

g/24h

0.30

206

(3048929) Epstein Barr virus Ab [Presence] in Serum

124

671

1.88

9.78

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

269

1795

1.54

9.74

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

490

2.03

9.72

1.4

—

17.89

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

183

1118

1.67

9.55

1.7

1.9

39.43

39.51

u/l

0.02

165

977

(3033705) Calcium.ionized [Moles/volume] in Venous blood

328

2.25

9.52

3.1

2.2

1.20

mmol/l

0.05

321

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

440

2.07

9.50

1.5

1.4

133.61

156.02

au/ml

0.77

142

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

188

1159

1.66

9.48

2.0

2.6

2.90

2.98

g/l

0.52

165

1050

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

126

694

1.85

9.42

1.6

2.0

11.28

11.84

mg/l

0.34

118

635

(3021589) Normoblasts [#/volume] in Blood

1418

12345

1.26

9.38

15.8

11.4

0.00

e9/l

0.36

1211

10053

(3016650) Hepatitis A virus Ab [Presence] in Serum

409

2.11

9.35

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

935

7760

1.29

9.13

5.0

3.4

0.00

0.26

estimate

1.14

277

2480

(3041354) Potassium [Moles/volume] in Venous blood

336

2.20

9.00

3.1

2.2

4.10

mmol/l

0.03

329

(3035285) Chloride [Moles/volume] in Venous blood

336

2.20

9.00

3.1

2.2

104.64

105.50

mmol/l

0.61

329

(1761482) Bacteria [#/volume] in Urine by Culture

123

683

1.83

8.97

5.6

4.1

—

(3021901) Oxygen saturation in Capillary blood

112

605

1.88

8.91

4.0

2.8

89.20

89.49

0.18

107

589

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

133

758

1.79

8.91

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

140

811

1.76

8.87

1.4

1.5

1.27

2.19

iu/ml

0.23

151

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

184

1154

1.63

8.69

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

111

609

1.85

8.43

2.5

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

359

2.11

8.40

6.9

6.6

12.10

12.29

mg/l

0.13

338

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

129

742

1.77

8.40

1.9

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

124

705

1.79

8.39

1.6

12956.61

13556.09

e6/l

0.06

483

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

483

1.95

8.34

1.3

1.2

—

51.07

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

396

2.05

8.21

1.7

1.5

0.65

0.80

g/l

0.90

306

(3039000) Anion gap in Blood by calculation

108

593

1.85

8.20

7.9

6.5

11.47

11.27

mmol/l

0.21

101

531

(3018572) Chloride [Moles/volume] in Blood

108

593

1.85

8.20

8.0

6.5

104.58

105.15

mmol/l

0.48

101

532

(3022621) pH of Urine by Test strip

308

2190

1.45

8.17

3.5

2.7

6.08

6.05

0.23

219

1536

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

125

721

1.76

8.07

1.8

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

125

725

1.75

7.93

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

129

756

1.73

7.89

3.5

3.3

1.33

1.86

index

0.68

387

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.49

7.81

3.0

1.3

11.98

14.71

g/l

0.66

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

502

1.90

7.79

1.7

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

6.95

7.76

1.7

2.0

50.73

23.88

pmol/l

1.64

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

172

1093

1.61

7.73

2.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

115

657

1.78

7.69

2.5

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.35

7.65

3.4

1.9

4473.71

4287.43

e6/l

0.02

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

236

1614

1.50

7.64

3.0

3.6

4.23

4.45

pmol/l

3.08

207

1427

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

287

2.18

7.59

1.4

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

254

1767

1.47

7.56

2.4

25.96

23.37

au/ml

0.14

182

(1616796) Gas panel - Central venous blood

111

631

1.79

7.55

4.7

3.7

—

(4198724) Urine methamphetamine measurement

3.49

7.53

2.2

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

530

1.86

7.51

2.5

1.7

1.02

0.87

nmol/l

1.09

451

(3000764) Benzodiazepines [Presence] in Urine

115

663

1.76

7.46

2.5

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

157

985

1.62

7.44

2.9

3.0

0.31

0.34

iu/ml

0.92

527

(3027008) Opiates [Presence] in Urine

115

664

1.76

7.43

2.5

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

579

4628

1.30

7.36

3.8

3.1

2.14

2.52

e6/l

0.58

323

2240

(3025468) Yersinia sp identified in Specimen by Organism specific culture

278

2.18

7.35

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

278

2.18

7.35

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

527

1.85

7.33

1.6

1.3

—

(3028300) Cannabinoids [Presence] in Urine

115

668

1.75

7.28

2.5

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

102

573

1.80

7.23

1.7

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

280

2.16

7.22

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

300

2.12

7.21

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

295

2.12

7.11

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

231

2.27

7.06

2.4

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

622

1.76

7.06

1.8

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

194

2.39

7.02

1.6

1.9

8.72

6.78

umol/l

0.36

132

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

420

1.93

7.01

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.50

6.98

1.3

1.5

9.22

8.72

ug/l

0.27

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

165

1067

1.57

6.92

2.0

2.5

0.39

1.04

g/l

3.69

138

906

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

299

2.09

6.88

1.2

1.3

—

nmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

727

1.69

6.81

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

268

2.15

6.76

1.4

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

160

1035

1.57

6.71

2.1

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

309

2.06

6.70

1.3

56.65

44.64

u/ml

0.19

(3045683) HLA typing for celiac disease panel - Blood or Tissue

121

2.74

6.69

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

296

2.08

6.67

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

449

1.87

6.67

1.3

1.2

323.38

257.26

u/ml

1.08

274

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

231

1620

1.46

6.62

1.3

38.11

58.06

au/ml

—

120

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

260

1867

1.43

6.56

2.0

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

334

2504

1.37

6.55

5.3

4.3

0.22

0.13

0.72

100

692

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

156

1011

1.57

6.50

2.0

1.8

—

(40768804) Tissue Pathology biopsy report

1241

10954

1.21

6.45

2.3

2.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.93

6.43

1.4

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.93

6.42

2.8

2.6

20.37

102.24

ug/l

0.52

(3010375) cycloSPORINE [Mass/volume] in Blood

2.98

6.38

31.5

27.2

127.14

105.79

ug/l

1.08

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2687

25587

1.26

6.37

8.5

6.4

40.83

39.60

mmol/mol

8.79

2532

23808

(3002179) Metamyelocytes/Leukocytes in Blood

328

2475

1.36

6.17

5.3

4.1

0.75

0.67

0.22

118

740

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

313

2.00

6.13

1.1

1.2

0.18

0.25

nmol/l

0.59

251

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

3.09

6.03

3.1

7.80

7.95

mg/l

0.04

(3024928) Oxygen saturation in Venous blood

121

753

1.63

5.99

2.6

62.09

61.44

0.12

115

732

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

296

2.01

5.94

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

140

905

1.57

5.93

2.0

2.5

0.03

0.02

g/l

0.21

126

811

(3040151) Glucose [Moles/volume] in Capillary blood

324

1.96

5.92

107.2

6.2

8.33

7.16

mmol/l

1.33

280

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

128

811

1.60

5.90

2.1

2.5

0.00

g/l

-0.00

120

764

(4024509) Urine culture

187

1293

1.47

5.79

1.9

2.0

—

(3044889) 12 lead EKG panel

2107

19644

1.20

5.78

5.4

4.1

0.40

8957.63

—

(3011288) Drugs identified in Urine by Screen method Nominal

464

1.79

5.75

4.0

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

132

849

1.58

5.72

2.0

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

517

1.74

5.71

2.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

541

1.72

5.66

1.7

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

526

1.73

5.66

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

135

878

1.56

5.59

2.0

2.5

0.00

g/l

-0.00

120

765

(3000012) Reticulocyte production index

455

1.78

5.53

3.2

2.1

0.90

0.85

0.37

300

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

134

2.48

5.53

1.7

2.6

706.48

1127.49

u/ml

0.95

134

(3037121) Protein [Mass/volume] in Urine

145

961

1.53

5.52

2.7

3.6

496.93

355.51

mg/l

0.47

424

(3023419) Bacteria identified in Sputum by Culture

363

1.86

5.43

2.6

2.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

356

1.87

5.42

2.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

356

1.87

5.42

2.0

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

356

1.87

5.42

2.0

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

356

1.87

5.42

2.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

490

1.73

5.34

2.2

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

281

1.97

5.31

1.1

1.50

2.52

eliau/ml

0.84

124

(3032773) Endomysium IgG Ab [Titer] in Serum

207

2.14

5.28

1.1

—

(3025159) Blasts/Leukocytes in Blood

326

2521

1.33

5.22

5.8

4.5

0.93

0.24

0.45

649

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

403

3208

1.29

5.22

5.5

4.9

33.55

32.55

1.04

288

2049

(3043410) Blood group antigens tested for on Red Blood Cells

3.06

5.21

2.5

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

376

1.83

5.18

1.9

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

177

2.22

5.12

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

230

2.06

5.11

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

230

2.06

5.11

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

230

2.06

5.11

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.19

5.09

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2860

27605

1.26

4.98

33.1

19.1

139.33

139.68

mmol/l

10.14

2823

27040

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

2.10

4.95

1.0

—

(3008295) Osmolality of Serum or Plasma

296

1.91

4.92

1.4

1.3

277.65

277.59

mosm/kgh2o

0.01

222

(3012501) Base excess in Blood by calculation

587

1.64

4.91

5.2

4.4

2.32

2.74

mmol/l

0.94

392

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.13

4.88

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.17

4.87

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

188

2.14

4.84

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

188

2.14

4.84

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

334

1.84

4.82

1.1

—

(3042733) HLA Ab [Presence] in Serum

3.08

4.79

3.7

5.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

189

2.13

4.78

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

538

1.65

4.75

2.8

2.0

6857.84

4694.41

u/l

0.18

227

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

232

1736

1.36

4.65

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

165

2.19

4.65

1.5

1.3

—

(1761868) Lipid panel - Serum or Plasma

892

10092

0.84

4.59

3.9

3.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

186

2.11

4.57

1.1

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

160

2.20

4.55

1.5

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

194

2.07

4.49

1.3

1.2

157.14

86.49

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2860

27672

1.24

4.43

33.3

19.3

4.00

3.98

mmol/l

2.23

2823

27056

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

366

1.76

4.42

1.8

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

315

1.82

4.41

3.7

2.2

25.17

23.90

mg/l

0.07

119

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.21

4.33

1.3

1.2

0.29

95.89

mg/l

0.50

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

281

1.86

4.32

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

393

1.72

4.25

4.7

5.4

342.85

354.61

umol/l

0.32

345

(21494434) Karyotype in Bone marrow

247

1.92

4.25

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.70

4.25

3.2

2.4

0.60

0.61

mmol/l

0.19

(3038026) Centromere Ab [Units/volume] in Serum

185

2.07

4.24

1.3

1.2

—

78.18

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.95

4.20

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.81

4.18

2.3

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

235

1.93

4.15

1.5

1.3

6.07

6.84

g/l

1.20

172

(3028192) IgG subclass 2 [Mass/volume] in Serum

235

1.93

4.15

1.5

1.3

2.71

2.83

g/l

0.22

171

(3024139) IgG subclass 3 [Mass/volume] in Serum

235

1.93

4.15

1.5

1.3

0.37

0.40

g/l

0.28

172

(3028433) Virus identified in Specimen by Culture

2.67

4.15

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

511

1.62

4.15

1.3

1.2

75.46

31.96

u/l

0.49

434

(3023511) Choriogonadotropin [Units/volume] in Urine

278

1.85

4.14

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.25

4.14

1.3

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.60

4.13

1.9

1.4

13.94

14.79

pmol/l

0.61

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

141

2.21

4.11

1.7

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

148

2.17

4.08

2.3

1.4

0.97

1.25

nmol/l

0.92

107

(3041672) Baker's yeast Ab [Presence] in Serum

8.02

4.06

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.51

4.04

1.7

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

674

1.53

4.03

3.2

3.3

0.77

0.83

nmol/l

0.83

545

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

453

1.65

4.03

1.7

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

10.02

4.01

2.4

3.1

3.31

2.81

mg/l

—

(3044007) Cell count panel - Peritoneal fluid

2.60

3.97

3.2

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

246

1904

1.32

3.96

1.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

115

784

1.48

3.93

2.6

2.5

3.60

3.62

g/l

0.06

108

748

(21494755) Public health laboratory ask at order entry panel

153

2089

0.72

3.87

1.3

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

307

1.77

3.85

1.8

1.5

56.25

61.46

0.36

182

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

172

2.05

3.84

1.1

1.3

0.62

1.10

u/ml

0.32

102

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

376

1.69

3.79

2.3

1.7

—

(4062490) Immunoglobulin typing, IgG

236

1.88

3.78

1.6

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

8.77

3.77

1.7

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

880

0.58

3.70

1.1

1.2

1.47

1.53

g/l

1.01

880

(3008402) Methanol [Moles/volume] in Serum or Plasma

4.15

3.70

1.0

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.15

3.70

1.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

607

1.53

3.69

1.7

1.4

—

(3008898) HLA-B27 [Presence]

114

788

1.46

3.66

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

162

2.05

3.65

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.61

3.63

1.1

1.2

37.01

37.88

g/l

0.11

(3000060) B lymphocytes [#/volume] in Blood

2.87

3.62

2.4

0.15

e9/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

485

1.58

3.54

1.9

4.63

4.90

mmol/24h

0.31

422

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

124

2.19

3.54

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

124

2.19

3.54

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

124

2.19

3.54

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

124

2.19

3.54

1.3

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

144

2.09

3.53

1.8

2.7

451.48

473.71

e6/l

0.11

119

(3015956) Eosinophils/Leukocytes in Blood by Manual count

3.62

3.49

1.3

2.0

4.42

2.18

0.84

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2691

26015

1.18

3.48

6.3

5.2

6.19

5.98

mmol/l

10.56

2505

23726

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.89

3.46

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

2.10

3.43

1.8

3.2

1.31

1.14

0.26

139

(3022493) Free Hemoglobin [Mass/volume] in Plasma

107

2.25

3.38

1.1

7.0

51.87

61.13

mg/l

0.30

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

147

2.05

3.36

1.9

2.9

159.08

214.50

e6/l

1.26

129

(3052592) Norovirus Ag [Presence] in Stool

2.92

3.29

1.1

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

191

1.89

3.24

1.9

—

(3035933) Granulocytes/Leukocytes in Blood

586

1.50

3.21

4.9

3.3

58.06

58.25

0.05

586

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

201

2562

0.77

3.20

2.2

2.1

3.72

3.50

ratio

1.48

154

2022

(40768443) Skin Pathology biopsy report

160

1204

1.35

3.18

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

6.37

3.18

2.9

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

688

1.45

3.14

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

172

1.93

3.14

2.1

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

209

1638

1.29

3.13

1.2

107.98

149.83

u/ml

0.72

593

(40757373) Influenza virus identified in Isolate

2.69

3.05

2.1

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

112

801

1.41

3.05

2.5

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

300

1.68

3.02

3.5

3.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.84

3.02

3.4

2.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

278

1.70

2.99

3.6

3.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

100

2.21

2.99

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

100

2.21

2.99

1.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

101

712

1.43

2.98

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

204

1.82

2.98

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

226

1.78

2.98

1.9

2.6

1244.61

1071.60

e6/l

0.55

204

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.35

2.98

1.2

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.47

2.95

1.0

—

(40768800) Prostate Pathology biopsy report

616

0.56

2.95

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

263

2141

1.25

2.90

1.4

—

(3042631) Mycobacterium sp identified in Specimen

383

1.58

2.86

2.5

2.8

—

(3014271) Vancomycin [Susceptibility]

143

1.97

2.84

3.5

2.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.20

2.83

1.2

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.20

2.83

1.2

1.8

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

116

2.08

2.82

1.5

1.4

53.11

65.37

0.81

101

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

112

814

1.39

2.81

3.2

3.1

1.82

1.59

mg/l

1.70

102

728

(40768446) Kidney Pathology biopsy report

2.23

2.80

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

284

1.66

2.79

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

289

2391

1.23

2.76

6.2

3.9

1.23

mmol/l

0.29

258

2043

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

152

1.92

2.75

1.2

1.4

4.94

6.42

u/l

1.36

135

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.31

2.74

1.6

0.52

0.44

ug/l

0.31

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

499

5697

0.85

2.70

3.2

0.85

0.78

ug/l

0.29

351

3717

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.15

2.70

1.2

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

241

1.71

2.70

1.1

1.2

—

(3024471) HLA-A [Type]

2.51

2.70

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.18

2.67

2.0

3.2

23.55

30.34

umol/l

1.66

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2655

25786

1.15

2.61

24.1

16.1

77.35

78.19

ml/min/173m2

1.23

2511

23944

(3005570) Glucose [Moles/volume] in Urine

275

1.65

2.58

2.0

2.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.13

2.54

2.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

403

1.52

2.54

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

585

1.43

2.51

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

585

1.43

2.51

1.4

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

611

1.42

2.49

1.5

103.20

998.69

e6/l

2.70

484

(3003329) Lymphocytes/Leukocytes in Synovial fluid

255

1.66

2.48

1.7

1.5

29.73

30.85

0.06

149

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

629

1.41

2.47

1.2

1.3

197.56

212.65

miu/ml

0.11

285

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

597

1.42

2.44

1.4

1.5

16.23

38.88

e6/l

0.72

446

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2305

22224

1.12

2.42

37.1

20.7

330.99

332.01

g/l

5.98

2295

22068

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.01

2.40

1.5

1.3

421.30

449.03

nmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

250

1.65

2.39

2.4

29.99

31.32

iu/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

361

0.50

2.38

1.4

1.5

53.17

62.60

ug/l

0.49

293

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.26

2.37

1.0

—

(3024932) HLA-DR beta [Type]

2.42

2.36

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.83

2.34

1.3

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

698

1.37

2.29

1.8

2.0

3.09

12.43

iu/l

0.56

270

(4133840) Spirometry

2.38

2.29

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.38

2.29

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.38

2.29

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.62

2.27

2.8

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

171

1.76

2.24

1.9

1.4

81.77

82.55

umol/l

0.05

171

(3047189) Immunofixation for 24 hour Urine

142

1.84

2.23

2.0

1.6

—

(3034092) Cytoplasmic Ig cells/cells in Blood

3.11

2.22

31.8

9.0

0.46

0.20

—

(3039443) Prostate specific Ag panel - Serum or Plasma

517

0.60

2.22

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2577

25057

1.13

2.20

5.2

4.3

1.36

1.29

mmol/l

4.28

2415

22863

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

173

1.74

2.16

2.4

1.8

129.21

118.34

ng/l

0.21

173

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.29

2.15

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

159

1.77

2.13

2.5

2.7

39.16

39.13

0.00

(3017354) Segmented neutrophils/Leukocytes in Blood

299

1.55

2.11

4.0

3.1

59.95

57.24

0.38

252

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

284

1.56

2.08

1.5

1.3

1.57

1.51

nmol/l

0.12

254

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

633

1.37

2.08

1.2

1.3

3.98

3.77

mmol/l

0.61

597

(3035320) C reactive protein [Mass/volume] in Body fluid

191

1.68

2.06

3.1

2.7

34.25

32.39

mg/l

0.08

135

(4146454) Self-monitoring of blood glucose

285

1.55

2.05

3.4

2.5

—

(3044009) aPTT.lupus sensitive (LA screen)

3.51

2.05

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

139

1.80

2.04

1.2

1.1

138.24

135.82

nmol/l

0.07

139

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.18

2.04

2.2

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

722

1.34

2.03

1.5

1.7

285.93

298.78

mu/l

0.25

664

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1.85

2.02

1.5

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.08

2.01

2.0

1.7

46.00

39.12

umol/l

—

(3033099) Centromere Ab [Titer] in Serum

2.50

2.01

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

208

1.64

2.01

1.2

102.94

pmol/l

0.00

208

(3049717) Cytology report of Urine Cyto stain

139

1104

1.27

1.98

2.7

2.6

—

(3017704) Immunofixation for Urine

163

1.72

1.98

1.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

141

1.78

1.96

1.3

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

336

0.53

1.96

1.3

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.98

1.95

1.3

1.4

111.86

126.08

nmol/l

—

(3004809) Band form neutrophils/Leukocytes in Blood

482

1.40

1.88

3.9

3.2

0.70

1.42

3.35

421

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.19

1.88

1.9

2.9

0.86

0.68

u/field

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.65

1.86

4.0

2.1

17.59

19.70

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

433

1.42

1.85

1.1

0.57

1.74

u/ml

2.16

236

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.98

1.84

1.4

1.2

0.32

0.31

g/l

0.20

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

293

1.51

1.84

1.3

25.30

30.34

u/l

0.41

243

(3045424) Erythrocytes [Presence] in Urine

164

1341

1.23

1.84

2.2

0.00

0.59

estimate

0.51

433

(3006462) Nitrate [Presence] in Urine

122

1.81

1.84

3.5

3.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

214

1.59

1.82

2.4

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

208

1.59

1.76

1.6

1.4

15.09

13.13

u/l

0.94

198

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

102

795

1.29

1.72

2.5

2.3

96.57

92.26

1.18

771

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.0

1.2

—

(40768441) Liver Pathology biopsy report

186

1.62

1.72

1.6

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

204

1723

1.20

1.68

1.6

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

293

0.54

1.67

1.4

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

268

1.50

1.66

1.1

—

43.22

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.89

1.65

1.0

—

7.43

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.89

1.65

1.4

1.9

—

(3004451) EKG impression Narrative

181

1.61

1.63

2.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

1.67

1.63

3.2

3.9

—

(40762814) Titanium [Mass/volume] in Blood

2.38

1.61

2.4

4.66

4.85

ug/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

128

1.72

1.60

1.8

1.6

2.57

2.23

u/field

0.06

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

672

1.30

1.59

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2744

26908

1.11

1.59

6.8

5.8

2.55

2.68

mmol/l

12.32

2592

24895

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2700

26455

1.11

1.59

6.1

5.1

4.43

4.61

mmol/l

14.71

2551

24549

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

338

0.59

1.58

1.3

1.5

0.87

1.18

ratio

1.53

210

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

338

0.59

1.58

1.3

1.4

1.25

1.19

ratio

0.12

210

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

338

0.59

1.58

1.3

1.5

1.04

0.96

ratio

0.59

210

(4211845) Urine protein measurement

136

1.70

1.58

3.5

2.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

354

1.42

1.58

1.1

0.58

1.18

u/ml

0.79

146

(3019174) dRVVT (LA screen)

3.00

1.58

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

3.00

1.58

1.2

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.70

1.58

1.1

1.0

86.86

86.15

titre

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

157

1881

0.83

1.56

1.8

3.64

3.47

mmol/l

1.03

106

1332

(4027681) Cerebrospinal fluid IgG ratio and IgG index

145

1.66

1.54

1.1

1.2

0.50

0.54

ratio

0.62

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.43

1.53

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

366

1.40

1.51

1.1

1.52

4.25

u/ml

1.99

184

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2871

28245

1.12

1.49

17.8

11.9

26.04

26.02

u/l

0.01

2802

27330

(4268621) Lupus anticoagulant assay

267

1.47

1.48

2.1

2.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

116

1.73

1.48

2.2

1.6

37.77

39.82

g/l

0.72

116

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

376

1.39

1.48

1.2

3.41

5.30

u/ml

0.64

164

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.44

1.47

3.7

6.2

—

2075.60

—

(1617658) Protocol used for examination of sentinel lymph nodes

229

0.52

1.46

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

558

1.32

1.46

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

637

1.29

1.46

1.2

1.4

10.76

9.90

u/l

0.17

520

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.23

1.46

2.0

1.5

5.80

7.61

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2902

28578

1.12

1.44

35.2

21.2

83.04

79.03

umol/l

4.71

2870

28197

(3003434) Protein [Mass/volume] in Pleural fluid

447

1.35

1.43

1.8

1.4

30.20

31.65

g/l

0.42

409

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

151

0.46

1.43

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.25

1.40

13.1

12.2

4.41

5.51

mmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.86

1.40

1.4

1.3

2.28

459.47

ug/l

—

(3017569) Oxygen content in Arterial blood

173

1.57

1.40

2.8

2.3

15.65

16.12

0.26

173

(3020491) Glucose [Moles/volume] in Blood

181

1.55

1.40

1.6

2.4

8.05

6.78

mmol/l

0.73

123

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

416

1.35

1.37

1.1

2807.92

1499.17

iu/ml

0.17

(3023199) Leukocytes [#/volume] in Pleural fluid

392

1.36

1.34

1.7

1.3

1423.41

3865.13

e6/l

0.56

277

(3047352) Trisomy 18 risk [Likelihood] in Fetus

284

0.60

1.33

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.30

2.3

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

292

1.41

1.30

1.0

1.1

—

2.78

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

284

1.41

1.29

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.36

1.29

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.78

1.28

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.82

1.25

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

1.49

1.24

1.7

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

121

1007

1.21

1.23

1.3

1.4

30.11

29.22

iu/l

0.11

102

862

(40765096) Chromosome analysis panel by Banding

108

1.67

1.22

1.3

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.63

1.21

1.2

1.0

4.08

5.33

nmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2671

26254

1.09

1.18

5.9

5.0

1.41

1.46

mmol/l

8.24

2517

24216

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

223

1.44

1.16

1.7

376.70

319.60

mu/l

0.36

177

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

337

3046

1.12

1.16

4.9

3.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.50

1.15

1.0

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

174

1.50

1.15

1.2

1.4

176.90

210.19

pmol/l

0.26

174

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

610

0.75

1.14

1.5

1.6

903.81

1031.26

mu/l

0.40

494

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

134

1.57

1.14

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

155

0.51

1.13

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.34

1.12

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.34

1.12

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.34

1.12

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

143

1.54

1.11

21.8

18.1

1410.59

1418.28

nmol/l

0.02

138

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

234

1.41

1.10

1.8

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

243

1.40

1.09

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

152

1.52

1.08

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

136

1.55

1.08

1.8

1.4

4.50

3.12

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.93

1.06

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.12

1.05

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

407

0.71

1.05

1.4

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

1.1

0.04

0.02

u/ml

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.27

1.03

2.6

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

106

1.61

1.02

1.1

0.78

1.30

u/ml

—

(4195642) Thrombophilia screening test

350

1.32

1.02

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

114

1.58

1.02

1.1

0.28

0.25

u/ml

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.81

0.98

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.18

0.98

1.0

1.2

11.00

10.87

u/l

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

318

1.32

0.97

1.6

2.3

—

3.44

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

173

1.45

0.97

1.5

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.95

0.97

2.4

2.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

749

1.21

0.97

2.8

2.6

205.48

195.56

0.44

713

(40768793) Breast Pathology biopsy report

692

0.79

0.96

1.3

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

381

1.29

0.95

1.2

2.09

4.06

u/ml

1.06

139

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.69

0.95

1.2

1.5

67.38

176.39

nmol/24h

0.71

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

996

9522

1.07

0.94

5.3

5.5

3.14

3.58

ug/l

0.13

895

8607

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.89

0.94

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

0.92

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

673

1.21

0.90

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

861

0.82

0.90

2.3

1.8

3.82

4.09

mg/l

0.11

644

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

262

1.34

0.89

1.7

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.07

0.89

1.5

1.3

—

99.38

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.79

0.87

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

0.87

1.7

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.00

0.87

1.0

1.2

—

(3036489) Thrombin time

117

1010

1.16

0.86

2.3

2.1

20.58

21.04

0.49

103

906

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

238

1.35

0.86

1.8

2.0

1.76

1.52

u/field

0.15

120

(3035880) pH of Pleural fluid

170

1.41

0.85

1.5

1.3

7.43

0.01

121

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

1.54

0.84

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

239

1.34

0.84

3.1

3.4

84.18

38.54

mg/l

0.36

182

(3051611) Lipemic interference index of Serum or Plasma

274

1.32

0.83

3.4

3.3

13.44

11.96

index

0.29

149

(3023410) Appearance of Cerebral spinal fluid

257

1.33

0.83

1.6

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.65

0.81

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

346

1.28

0.81

1.6

1.3

76007.63

80269.44

e6/l

0.03

196

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

189

1.38

0.81

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

172

1.40

0.80

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

329

1.28

0.80

1.2

—

(40768806) Pleura Pathology biopsy report

329

1.28

0.80

1.6

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

303

1.29

0.79

1.3

7.15

7.47

mmol/l

0.21

265

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

207

1.36

0.79

1.0

814.19

713.49

ng/l

0.46

129

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.79

0.0

6.5

—

7.68

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.79

0.0

3.2

—

43.04

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

277

1.30

0.78

1.1

2.42

3.22

u/ml

0.16

117

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

277

1.30

0.78

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.67

0.78

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

0.50

0.77

1.6

1.9

0.00

0.06

estimate

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

208

1.35

0.77

1.0

304.14

310.58

ng/l

0.07

135

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

779

1.17

0.76

1.3

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

209

1.34

0.75

1.0

40.99

40.89

ng/l

0.01

135

(4015189) Microbial culture of sputum

1.70

0.75

1.9

2.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.73

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

2.00

0.72

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.58

0.71

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

109

1.47

0.70

1.4

1.3

132.00

167.58

mmol/24h

1.42

109

(3011897) Casein IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

1.1

0.00

0.67

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

1.92

0.70

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

221

1.31

0.69

2.1

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.63

0.66

1.0

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.79

0.66

1.4

1.1

17.52

17.09

g/l

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.79

0.66

3.0

6.2

73.60

59.52

ug/min

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

1.24

0.65

1.1

0.82

1.25

u/ml

0.53

173

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

137

1.39

0.64

18.2

14.7

838.89

824.45

nmol/l

0.06

132

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

172

1.34

0.63

1.8

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2258

22241

1.05

0.62

32.0

19.8

14.08

13.69

26.08

2247

21907

(44786800) Granulocytes/Leukocytes in Body fluid

1.67

0.61

1.4

37.80

19.35

—

(3045142) Bone marrow Pathology biopsy report

318

1.23

0.58

1.6

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.72

0.57

2.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.72

0.57

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.48

0.57

1.4

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

115

1.39

0.56

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

403

1.19

0.55

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

403

1.19

0.55

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

376

1.20

0.54

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.50

0.51

1.2

1.3

61.33

67.17

ug/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

135

1.34

0.51

1.3

1.1

—

(4281824) Cell count and differential, peritoneal fluid

303

0.79

0.51

1.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.39

0.50

2.1

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.46

0.50

1.0

1.2

41.00

40.98

mg/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.46

0.50

1.2

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.43

0.49

1.4

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.45

0.48

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

256

0.78

0.48

1.7

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.49

0.47

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

240

2249

1.07

0.47

5.5

4.0

—

(3012441) Differential panel - Pleural fluid

327

1.19

0.47

1.9

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.47

0.47

1.0

1.2

91.00

87.03

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.41

0.46

3.5

2.4

5.12

4.88

kpa

0.48

(40765089) Chromosome analysis panel - Blood by G-banded

1.46

0.46

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.40

0.44

3.5

2.4

10.18

10.30

kpa

0.06

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

121

1.32

0.44

1.2

1.1

13.20

397.20

ng/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

404

1.17

0.44

1.1

19.99

18.88

au/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

148

1.29

0.43

1.1

0.97

1.16

u/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

166

1.27

0.43

1.9

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.61

0.43

3.0

2.9

1.16

0.65

ug/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.61

0.43

2.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.43

0.42

1.3

1.4

1.14

1.17

mmol/l

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

122

1.31

0.42

8.3

12.8

0.53

0.63

mmol/l

0.84

117

(3041806) Other cells [#/volume] in Blood by Manual count

1.52

0.41

1.0

1.6

0.64

0.51

e9/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.4

—

332.53

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

1.30

0.40

1.0

1.1

2091.44

1492.77

miu/ml

1.38

123

(3005011) Chlamydia sp Ab [Titer] in Serum

1.47

0.40

1.2

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.40

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.40

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

602

0.88

0.39

4.8

3.6

20.34

26.97

mg/l

1.16

424

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

297

1.18

0.39

1.5

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

344

1.16

0.38

4.9

3.0

11.35

10.60

mmol/l

0.41

337

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.38

0.38

1.0

1.1

—

(3024263) Appearance of Synovial fluid

152

1.25

0.37

1.4

1.5

—

(3034426) Prothrombin time (PT)

0.66

0.35

1.2

1.3

28.20

28.94

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.36

0.34

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.34

0.34

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.67

0.33

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

741

7596

0.97

0.32

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

1.23

0.30

1.0

1.1

—

(3035941) MCH [Entitic mass]

2921

29076

1.04

0.29

42.7

24.1

30.27

30.39

3.03

2889

28699

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2921

29077

1.04

0.28

42.8

24.1

91.37

91.38

0.07

2890

28700

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2921

29078

1.04

0.28

43.5

24.7

39.29

40.19

15.69

2887

28686

(3026361) Erythrocytes [#/volume] in Blood

2921

29079

1.04

0.28

42.9

24.2

4.36

4.46

e12/l

20.40

2874

28314

(44806420) Estimation of glomerular filtration rate

290

0.86

0.27

2.9

2.4

—

(3007461) Platelets [#/volume] in Blood

2920

29072

1.04

0.27

42.9

24.2

247.64

247.94

e9/l

0.08

2877

28415

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

121

0.74

0.27

1.0

1.2

9.11

11.21

mm/h

—

121

(3010813) Leukocytes [#/volume] in Blood

2921

29083

1.04

0.27

43.0

24.2

7.05

6.78

e9/l

4.54

2875

28312

(3000963) Hemoglobin [Mass/volume] in Blood

2921

29086

1.04

0.26

43.4

24.4

130.90

134.74

g/l

32.43

2890

28724

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

379

3673

1.04

0.25

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.25

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

750

7651

0.97

0.25

4.8

4.5

22.62

21.98

0.56

377

3846

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.71

0.24

1.0

3.0

171.00

184.44

—

(21494814) CD8 cells/Lymphocytes in Specimen

106

1.23

0.23

1.7

2.2

32.69

29.20

0.29

106

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.28

0.23

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

304

1.12

0.22

1.1

1.78

2.22

u/ml

0.17

150

(3001019) Free T4 and TSH panel - Serum or Plasma

108

1143

0.94

0.22

1.5

1.7

—

(3022689) Creatine [Moles/volume] in Urine

0.74

0.22

1.1

1.5

10.34

7.80

mmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

182

1.15

0.21

2.9

2.1

8.33

8.22

mmol/l

0.04

182

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.16

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

0.17

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.14

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

268

1.12

0.20

1.7

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

1.18

0.19

2.3

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.18

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.19

0.18

1.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.15

0.17

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

139

1.15

0.16

2.1

2.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.11

0.15

1.0

1.2

—

(4035726) Immunohistochemistry procedure

256

2496

1.03

0.15

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

235

2291

1.03

0.14

2.3

12.73

13.12

nmol/l

0.31

212

2072

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

354

1.07

0.13

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

287

1.08

0.12

1.6

1.9

—

1128.00

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.15

0.10

1.1

1.0

0.23

1.14

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.11

0.09

7.8

9.82

10.44

—

(21491868) Cryoglobulin [Mass/volume] in Serum

106

1.13

0.09

1.0

1.3

—

0.23

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

155

1.10

0.09

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

233

1.07

0.09

5.0

5.9

47.62

48.40

u/ml

—

(3045788) Cell count panel - Pleural fluid

331

1.06

0.08

1.8

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.78

0.08

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.84

0.07

10.5

6.6

74.83

70.78

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

149

1.07

0.05

1.2

—

(3002256) Pathology report gross observation

380

3831

0.99

0.05

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

262

0.95

0.04

1.1

1.0

0.12

0.20

u/ml

0.23

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.09

0.03

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.09

0.03

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.09

0.03

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.09

0.03

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1139

11408

1.00

0.02

2.0

1.9

1.46

1.35

mmol/l

2.44

961

9580

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

106

0.94

0.01

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

116

0.95

0.00

1.0

2.7

165.36

164.63

0.01

110

(1002224) Polysomnography panel

119

1197

0.99

0.00

1.1

—

(40768795) Lymph node Pathology biopsy report

294

1.02

0.00

1.5

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

135

1.04

0.00

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

215

0.98

0.00

1.3

1.6

60.37

55.90

ug/l

0.24

215

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

214

0.98

0.00

1.5

1.2

—

(3025130) Human papilloma virus identified in Specimen

357

1.01

0.00

2.2

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.98

0.00

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.02

0.00

8.7

8.5

5.42

5.44

kpa

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.00

0.00

3.5

2.4

1.08

1.11

ug/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.18

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.35

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

150

1.00

-0.00

1.2

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.95

-0.00

1.1

1.0

97.67

91.83

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

150

1.00

-0.00

1.2

1.5

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

343.00

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.98

-0.00

2.2

2.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.98

-0.00

2.2

2.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

2.80

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.86

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ACUTGASTR and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ACUTGASTR	1.501 [1.39, 1.62]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.505

During the follow-up period (1.1.1998 — 31.12.2019), 3509 out of 10649 females with K11_ACUTGASTR died.

Males

Parameter	HR [95% CI]	p-value
K11_ACUTGASTR	1.956 [1.79, 2.13]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 3690 out of 9494 males with K11_ACUTGASTR died.

Mortality risk

Mortality risk for people of age

years, who have K11_ACUTGASTR.

N-year risk	Females	Males
1	0.169%	0.302%
5	0.945%	2.288%
10	2.344%	5.938%
15	4.395%	10.628%
20	7.829%	17.594%

Relationships between endpoints

↥

Index endpoint: K11_ACUTGASTR – Acute gastritis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acute gastritis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints